Shan Li

Title: The Innovations of Shan Li

Introduction

Shan Li is an accomplished inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on 2-aminopyrimidine compounds. His research focuses on developing effective treatments for various blood tumors and inflammatory diseases.

Latest Patents

Shan Li holds a patent for a class of 2-aminopyrimidine compounds, which are detailed in his patent titled "2-aminopyrimidine compound and pharmaceutical composition thereof and application thereof." This patent describes compounds that can efficiently and selectively inhibit the kinase activity of Janus Kinase 3 (JAK3). These compounds demonstrate strong signal inhibition and cell proliferation inhibition effects on various blood tumor cells, especially human acute myeloid leukemia cell U937 cells. The compounds can be utilized in the preparation of anti-tumor drugs and medications for preventing and treating inflammatory diseases. He has 1 patent to his name.

Career Highlights

Throughout his career, Shan Li has worked with notable organizations, including Guangzhou Salustier Biosciences Co., Ltd. and Jinan University. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.

Collaborations

Shan Li has collaborated with various professionals in his field, including his coworker Zhang Zhang. These collaborations have further enriched his research and development efforts.

Conclusion

Shan Li's work in the field of pharmaceuticals, particularly with 2-aminopyrimidine compounds, showcases his dedication to innovation and improving treatment options for serious health conditions. His contributions are significant and continue to impact the medical community positively.